Tolerance in organ transplantation: From conventional immunosuppression to extracellular vesicles

Frontiers in Immunology

Volumn 5, Issue AUG, 2014, Pages

  Monguió Tortajada, Marta ^a   Lauzurica, Ricardo ^b   Borràs, Francesc E ^a,b  

^a IVECAT Group Institut d'Investigació Germans Trias i Pujol ^*  (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Exosomes; Extracellular vesicles; Graft rejection; Graft survival; Organ transplantation; Tolerance; Transplantation immunology

Indexed keywords

EID: 84928751378     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00416     Document Type: Article

References (139)

1. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA. 2011. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 29:341-345.
2. André F, Chaput N, Schartz NEC, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu D-H, et al. 2004. Exosomes as Potent Cell-Free Peptide- Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells. J Immunol. 172:2126-2136.
3. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
4. Barrès CB, Lionel Bette-Bobillo, Pascale André, Sabine Mamoun, Robert Gabius, Hans-Joachim Vidal, Michel. 2009. Galectin-5 is bound onto the surface of rat reticulocyte exosomes and modulates vesicle uptake by macrophages. Blood. 115:696- 705.
5. Bastos-Amador P, Pérez-Cabezas B, Izquierdo-Useros N, Puertas MC, Martinez-Picado J, Pujol-Borrell R, Naranjo-Gómez M, Borràs FE. 2012. Capture of cell-derived microvesicles (exosomes and apoptotic bodies) by human plasmacytoid dendritic cells. J Leukoc Biol [Internet]. [cited 2012 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22319103
6. Bastos-Amador P, Royo F, Gonzalez E, Conde-Vancells J, Palomo-Diez L, Borras FE, Falcon-Perez JM. 2012. Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability. Underst Genome Regul Genet Divers Mass Spectrom. 75:3574-3584.
7. Bittencourt M de CP, Sylvain Contassot, Emmanuel Fresnay, Stéphanie Baron, Marie- Hélène Angonin, Régis Aubin, François Hervé, Patrick Tiberghien, Pierre Saas, Philippe. 2001. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood. 98:224-230.
8. Bolton EM, Bradley JA, Pettigrew GJ. 2008. Indirect Allorecognition: Not Simple but Effective. Transplantation. 85:667-669 10.1097/TP.0b013e3181664db3.
9. Bradley JA. 2004. Transplant Tolerance by Treg Therapy. Am J Transplant. 14:5-6.
10. Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L, Tetta C, Camussi G. 2012. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PloS One. 7:e33115.
11. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, O'Donnell MP, Rabb H. 2001. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest. 108:1283-1290.
12. Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC, Sordi A, Biancone L, Tetta C, Camussi G. 2012. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA dependent reprogramming of resident renal cells. Kidney Int. 82:412-427.
13. Casiraghi F, Perico N, Remuzzi G. 2013. Mesenchymal stromal cells to promote solid organ transplantation tolerance. Curr Opin Organ Transplant. 18:51-58.
14. Cecka JM. 2008. Kidney transplantation in the United States. Clin Transpl.1-18.
15. Chaput N, Schartz NEC, André F, Taïeb J, Novault S, Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M, et al. 2004. Exosomes as potent cell-free peptide based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J Immunol Baltim Md 1950. 172:2137-2146.
16. Cibrik D, Silva HTJ, Vathsala A, Lackova E, Cornu-Artis C, Walker RG, Wang Z, Zibari GB, Shihab F, Kim YS. 2013. Randomized Trial of Everolimus-Facilitated Calcineurin Inhibitor Minimization Over 24 Months in Renal Transplantation. Transplantation. 95:933-942 10.1097/TP.0b013e3182848e03.
17. Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. 2004. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J [Internet]. Available from: http://www.fasebj.org/content/early/2004/06/02/fj.03-1094fje.short Clinicaltrials.gov. Search of: dendritic cells tolerogenic - List Results - ClinicalTrials.gov [Internet]. [cited 2014 Jul 26]. Available from: https://clinicaltrials.gov/ct2/results?term=dendritic+cells+tolerogenic
18. Cocucci E, Racchetti G, Meldolesi J. 2009. Shedding microvesicles: artefacts no more. Trends Cell Biol. 19:43-51.
19. Conforti A, Scarsella M, Starc N, Giorda E, Biagini S, Proia A, Carsetti R, Locatelli F, Bernardo ME. 2014. Microvescicles Derived from Mesenchymal Stromal Cells Are Not as Effective as Their Cellular Counterpart in the Ability to Modulate Immune Responses In Vitro. Stem Cells Dev.
20. Denzer K, van Eijk M, Kleijmeer MJ, Jakobson E, de Groot C, J. Geuze H. 2000. Follicular Dendritic Cells Carry MHC Class II-Expressing Microvesicles at Their Surface. J Immunol. 165:1259-1265.
21. Divito SJ, Wang Z, Shufesky WJ, Liu Q, Tkacheva OA, Montecalvo A, Erdos G, Larregina AT, Morelli AE. 2010. Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation. Blood. 116:2694-2705.
22. Ekberg H, Tedesco-Silva H, Demirbas A, Vítko Š, Nashan B, Gürkan A, Margreiter R, Hugo C, Grinyó JM, Frei U, et al. 2007. Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation. N Engl J Med. 357:2562-2575.
23. Escudier B, Dorval T, Chaput N, Andre F, Caby M-P, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S, et al. 2005. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med. 3:10.
24. Ezzelarab MB, Zahorchak AF, Lu L, Morelli AE, Chalasani G, Demetris AJ, Lakkis FG, Wijkstrom M, Murase N, Humar A, et al. 2013. Regulatory Dendritic Cell Infusion Prolongs Kidney Allograft Survival in Nonhuman Primates. Am J Transplant. 13:1989- 2005.
25. Feng G, Gao W, Strom TB, Oukka M, Francis RS, Wood KJ, Bushell A. 2008. Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells. Eur J Immunol. 38:2512-2527.
26. Feng G, Wood KJ, Bushell A. 2008. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation. 86:578-589.
27. Franquesa M, Herrero E, Torras J, Ripoll E, Flaquer M, Gomà M, Lloberas N, Anegon I, Cruzado JM, Grinyó JM, Herrero-Fresneda I. 2012. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev. 21:3125-3135.
28. Garrovillo M, Ali A, Depaz HA, Gopinathan R, Oluwole OO, Hardy MA, Oluwole SF. 2001. Induction of Transplant Tolerance with Immunodominant Allopeptide-pulsed Host Lymphoid and Myeloid Dendritic Cells. Am J Transplant. 1:129-137.
29. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C, Camussi G. 2011. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 26:1474-1483.
30. Ge W, Jiang J, Baroja ML, Arp J, Zassoko R, Liu W, Bartholomew A, Garcia B, Wang H. 2009. Infusion of Mesenchymal Stem Cells and Rapamycin Synergize to Attenuate Alloimmune Responses and Promote Cardiac Allograft Tolerance. Am J Transplant. 9:1760-1772.
31. Geissler EK, Hutchinson JA. 2013. Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients. Curr Opin Organ Transplant. 18:408-415.
32. Gökmen MR, Lombardi G, Lechler RI. 2008. The importance of the indirect pathway of allorecognition in clinical transplantation. Curr Opin Immunol. 20:568-574.
33. Gould SJ, Raposo G. 2013. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles.
34. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:737-742.
35. Gutiérrez-Vázquez C, Villarroya-Beltri C, Mittelbrunn M, Sánchez-Madrid F. 2012. Transfer of extracellular vesicles during immune cell-cell interactions. Immunol Rev. 251:125-142.
36. Hall BM, Tran G, Hodgkinson SJ. 2009. Alloantigen specific T regulatory cells in transplant tolerance. Int Immunopharmacol. 9:570-574.
37. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC. 2001. Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo. J Exp Med. 194:769-780.
38. Hee Kim S, Bianco N, Menon R, Lechman ER, Shufesky WJ, Morelli AE, Robbins PD. 2006. Exosomes Derived from Genetically Modified DC Expressing FasL Are Anti inflammatory and Immunosuppressive. Mol Ther. 13:289-300.
39. Herrera OB, Golshayan D, Tibbott R, Salcido Ochoa F, James MJ, Marelli-Berg FM, Lechler RI. 2004. A novel pathway of alloantigen presentation by dendritic cells. J Immunol Baltim Md 1950. 173:4828-4837.
40. Hoogduijn MJ, Popp F, Verbeek R, Masoodi M, Nicolaou A, Baan C, Dahlke M-H. 2010. The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharmacol. 10:1496-1500.
41. Horibe EK, Sacks J, Unadkat J, Raimondi G, Wang Z, Ikeguchi R, Marsteller D, Ferreira LM, Thomson AW, Lee WPA, Feili-Hariri M. 2008. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Transpl Immunol. 18:307- 318.
42. Ikeguchi R, Sacks JM, Unadkat JV, Solari M, Horibe EK, Thomson AW, Lee AWP, Feili-Hariri M. 2008. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression. Transplantation. 85:237-246.
43. Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R, Lee H. 2014. Label free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotech. 32:490-495.
44. Izquierdo-Useros N, Lorizate M, Puertas MC, Rodriguez-Plata MT, Zangger N, Erikson E, Pino M, Erkizia I, Glass B, Clotet B, et al. 2012. Siglec-1 Is a Novel Dendritic Cell Receptor That Mediates HIV-1 Trans-Infection Through Recognition of Viral Membrane Gangliosides. PLoS Biol. 10:e1001448.
45. J. Ratajczak, M. Wysoczynski, F. Hayek, A. Janowska-Wieczorek, M. Z. Ratajczak. 2006. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 20:1487-1495.
46. Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borràs FE, Breakefield X, Budnik V, et al. 2012. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 10:e1001450.
47. Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S. 2014. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip. 14:1891-1900.
48. Katsuda T, Kosaka N, Takeshita F, Ochiya T. 2013. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. PROTEOMICS. 13:1637-1653.
49. Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman SL, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, et al. 2014. Long-Term Results in Recipients of Combined HLA-Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression. Am J Transplant. 14:1599-1611.
50. Kebriaei P, Robinson S. 2011. Mesenchymal Stem Cell Therapy in the Treatment of Acute and Chronic Graft versus Host Disease. Front Oncol. 1.
51. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, Nguyen AT, Malide D, Combs CA, Hall G, et al. 2006. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 203:1235-1247.
52. Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD. 2007. Effective Treatment of Inflammatory Disease Models with Exosomes Derived from Dendritic Cells Genetically Modified to Express IL-4. J Immunol. 179:2242-2249.
53. Kim S-H, Lechman ER, Bianco N, Menon R, Keravala A, Nash J, Mi Z, Watkins SC, Gambotto A, Robbins PD. 2005. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol Baltim Md 1950. 174:6440-6448.
54. Koch M, Lehnhardt A, Hu X, Brunswig-Spickenheier B, Stolk M, Bröcker V, Noriega M, Seifert M, Lange C. 2013. Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival. Transpl Immunol. 29:43-50.
55. Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, Epple M, Horn PA, Beelen DW, Giebel B. 2014. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia.
56. Lai RC, Yeo RWY, Tan KH, Lim SK. 2013. Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation. Regen Med. 8:197- 209.
57. Lai RC, Yeo RWY, Tan KH, Lim SK. 2014. Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation. Regen Med. 8:197- 209.
58. Lamparski HG, Metha-Damani A, Yao J-Y, Patel S, Hsu D-H, Ruegg C, Le Pecq J-B. 2002. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods. 270:211-226.
59. Lechler RI, Garden OA, Turka LA. 2003. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol. 3:147-158.
60. Lee K, Nguyen V, Lee KM, Kang SM, Tang Q. 2014. Attenuation of Donor-Reactive T Cells Allows Effective Control of Allograft Rejection Using Regulatory T Cell Therapy. Am J Transplant. 14:27-38.
61. Leslie M. 2011. Immunology. Regulatory T cells get their chance to shine. Science. 332:1020-1021.
62. Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, Wang M, Zhou Y, Zhu W, Li W, Xu W. 2013. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 22:845-854.
63. Li X, Li J-J, Yang J-Y, Wang D-S, Zhao W, Song W-J, Li W-M, Wang J-F, Han W, Zhang Z-C, et al. 2012. Tolerance Induction by Exosomes from Immature Dendritic Cells and Rapamycin in a Mouse Cardiac Allograft Model.Kassiotis G, editor. PLoS ONE. 7:e44045.
64. Lim WH, Turner RM, Chapman JR, Ma MKM, Webster AC, Craig JC, Wong G. 2014. Acute Rejection, T-Cell-Depleting Antibodies, and Cancer After Transplantation. Transplantation. 97:817-825 10.1097/01.TP.0000442773.38510.32.
65. Maggiore U, Oberbauer R, Pascual J, Viklicky O, Dudley C, Budde K, Sorensen SS, Hazzan M, Klinger M, Abramowicz D, for the ERA-EDTA-DESCARTES Working Group. 2014. Strategies to increase the donor pool and access to kidney transplantation: an international perspective. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc.
66. Marcén R. 2009. Immunosuppressive Drugs in Kidney Transplantation. Drugs. 69:2227-2243.
67. Marsh SGE. 2014. Nomenclature for factors of the HLA system, update March 2014. Int J Immunogenet. 41:351-360.
68. Meier-Kriesche H-U, Schold JD, Srinivas TR, Kaplan B. 2004. Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era. Am J Transplant. 4:378-383.
69. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan MLG, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang Z, et al. 2012. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood. 119:756- 766.
70. Montecalvo A, Shufesky WJ, Beer Stolz D, Sullivan MG, Wang Z, Divito SJ, Papworth GD, Watkins SC, Robbins PD, Larregina AT, Morelli AE. 2008. Exosomes As a Short- Range Mechanism to Spread Alloantigen between Dendritic Cells during T Cell Allorecognition. J Immunol. 180:3081-3090.
71. Montecalvo A, Shufesky WJ, Stolz DB, Sullivan MG, Wang Z, Divito SJ, Papworth GD, Watkins SC, Robbins PD, Larregina AT, Morelli AE. 2008. Exosomes as a short range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J Immunol Baltim Md 1950. 180:3081-3090.
72. Montgomery RA. 2014. One Kidney for Life. Am J Transplant. 14:1473-1474.
73. Moreau A, Varey E, Anegon I, Cuturi M-C. 2013. Effector Mechanisms of Rejection. Cold Spring Harb Perspect Med [Internet]. 3. Available from: http://perspectivesinmedicine.cshlp.org/content/3/11/a015461.abstract Moreau A, Varey E, Bériou G, Bouchet-Delbos L, Segovia M, Cuturi MC. 2012.
74. Moreau A, Varey E, Bériou G, Bouchet-Delbos L, Segovia M, Cuturi MC. 2012. Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials. Front Immunol. 3.
75. Morelli A, Larregina A. 2010. Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells. Apoptosis. 15:1083-1097.
76. Morelli AE, Larregina AT, Shufesky WJ, Sullivan MLG, Stolz DB, Papworth GD, Zahorchak AF, Logar AJ, Wang Z, Watkins SC, et al. 2004. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 104:3257-3266.
77. Morelli AE, Wang Z, Shufesky WJ, Larregina AT, Zahorchak AF, Logar AJ. 2003. Use of donor apoptotic cells is a safe and effective means to prolong graft survival through interaction with recipient dendritic cells (Abstract). Am J Transplant. 3:195.
78. Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, et al. 2005. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med. 3:9.
79. Muller L, Hong C-S, Stolz DB, Watkins SC, Whiteside TL. 2014. Isolation of biologically-active exosomes from human plasma. J Immunol Methods.
80. Nakamura K, Kitani A, Strober W. 2001. Cell contact- dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med. 194:629-644.
81. Naranjo-Gomez M, Raich-Regue D, Onate C, Grau-Lopez L, Ramo-Tello C, Pujol- Borrell R, Martinez-Caceres E, Borras F. 2011. Comparative study of clinical grade human tolerogenic dendritic cells. J Transl Med. 9:89.
82. Naslund TI, Gehrmann U, Qazi KR, Karlsson MCI, Gabrielsson S. 2013. Dendritic Cell-Derived Exosomes Need To Activate Both T and B Cells To Induce Antitumor Immunity. J Immunol. 190:2712-2719.
83. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EGA, Willemze R, Fibbe WE. 2006. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood. 108:2114- 2120.
84. Patel AN, Genovese J. 2011. Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy. Stem Cells Cloning Adv Appl. 4:61-72.
85. Pêche H, Heslan M, Usal C, Amigorena S, Cuturi MC. 2003. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation. 76:1503-1510.
86. Pêche H, Renaudin K, Beriou G, Merieau E, Amigorena S, Cuturi MC. 2006. Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC mismatched rat cardiac allograft model. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 6:1541-1550.
87. Pêche H, Trinité B, Martinet B, Cuturi MC. 2005. Prolongation of Heart Allograft Survival by Immature Dendritic Cells Generated from Recipient Type Bone Marrow Progenitors. Am J Transplant. 5:255-267.
88. Pileggi A, Xu X, Tan J, Ricordi C. 2013. Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials. Curr Opin Organ Transplant. 18:672-681 10.1097/MOT.0000000000000029.
89. Ponticelli C. 2011. Present and Future of Immunosuppressive Therapy in Kidney Transplantation. Transplant Proc. 43:2439-2440.
90. Prado N, Cañamero M, Villalba M, Rodríguez R, Batanero E. 2010. Bystander suppression to unrelated allergen sensitization through intranasal administration of tolerogenic exosomes in mouse. Mol Immunol. 47:2148-2151.
91. Pu L-Y, Wang X-H, Zhang F, Li X-C, Yao A-H, Yu Y, Lv L, Li G-Q. 2007. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4+CD25+ regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation. Surgery. 142:67-73.
92. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ. 1996. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 183:1161- 1172.
93. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, Ratajczak MZ. 2006. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 20:847-856.
94. RaÏch-Regué D, Grau-López L, Naranjo-Gómez M, Ramo-Tello C, Pujol-Borrell R, Martínez-Cáceres E, Borràs FE. 2012. Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients. Eur J Immunol. 42:771-782.
95. Read S, Malmström V, Powrie F. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 192:295-302.
96. Robbins PD, Morelli AE. 2014. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 14:195-208.
97. Rocha PN, Plumb TJ, Crowley SD, Coffman TM. 2003. Effector mechanisms in transplant rejection. Immunol Rev. 196:51-64.
98. Rogers NJ, Lechler RI. 2001. Allorecognition. Am J Transplant. 1:97-102.
99. Rostaing L, Charpentier B, Glyda M, Rigotti P, Hettich F, Franks B, Houbiers JGA, First R, Holman JM. 2013. Alefacept Combined With Tacrolimus, Mycophenolate Mofetil and Steroids in De Novo Kidney Transplantation: A Randomized Controlled Trial. Am J Transplant. 13:1724-1733.
100. Rostaing L, Vincenti F, Grinyó J, Rice KM, Bresnahan B, Steinberg S, Gang S, Gaite LE, Moal MC, Mondragón-Ramirez GA, et al. 2013. Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study. Am J Transplant. 13:2875-2883.
101. Rupert DLM, Lässer C, Eldh M, Block S, Zhdanov VP, Lotvall JO, Bally M, Höök F. 2014. Determination of Exosome Concentration in Solution Using Surface Plasmon Resonance Spectroscopy. Anal Chem. 86:5929-5936.
102. Russ GR, Tedesco-Silva H, Kuypers DR, Cohney S, Langer RM, Witzke O, Eris J, Sommerer C, von Zur-Mühlen B, Woodle ES, et al. 2013. Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results. Am J Transplant. 13:1746-1756.
103. Sacks JM, Kuo Y-R, Taieb A, Breitinger J, Nguyen VT, Thomson AW, Feili-Hariri M, Lee WPA. 2008. Prolongation of Composite Tissue Allograft Survival by Immature Recipient Dendritic Cells Pulsed with Donor Antigen and Transient Low-Dose Immunosuppression. Plast Reconstr Surg. 121:37-49 10.1097/01.prs.0000293754.55706.7f.
104. Saunderson SCD, Amy C. Crocker, Paul R. McLellan, Alexander D. 2013. CD169 mediates the capture of exosomes in spleen and lymph node. Blood. 123:208-216.
105. Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, Wood KJ. 2005. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med. 201:1925-1935.
106. Segura E, Nicco C, Lombard B, Véron P, Raposo G, Batteux F, Amigorena S, Théry C. 2005. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T cell priming. Blood. 106:216-223.
107. Spanish National Transplant Organization (ONT), World Health Organization (WHO). Global Observatory on Donation and Transplantation [Internet]. [cited 2014 Jul 25]. Available from: http://www.transplant-observatory.org/Pages/home.aspx
108. Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MRE. 2009. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant. 24:3225-3231.
109. Stoop JN, Harry RA, von Delwig A, Isaacs JD, Robinson JH, Hilkens CMU. 2010. Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses. Arthritis Rheum. 62:3656-3665.
110. Sudres M, Norol F, Trenado A, Grégoire S, Charlotte F, Levacher B, Lataillade J-J, Bourin P, Holy X, Vernant J-P, et al. 2006. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol Baltim Md 1950. 176:7761-7767.
111. Sun E, Gao Y, Chen J, Roberts AI, Wang X, Chen Z, Shi Y. 2004. Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. Cell Death Differ. 11:1258-1264.
112. Sundin M, Barrett AJ, Ringdén O, Uzunel M, Lönnies H, Dackland A-L, Christensson B, Blanc KL. 2009. HSCT recipients have specific tolerance to MSC but not to the MSC donor. J Immunother Hagerstown Md 1997. 32:755-764.
113. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 192:303-310.
114. Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T, Takakura Y. 2013. Visualization and in vivo tracking of the exosomes of murine melanoma B16- BL6 cells in mice after intravenous injection. J Biotechnol. 165:77-84.
115. Taner T, Hackstein H, Wang Z, Morelli AE, Thomson AW. 2005. Rapamycin-Treated, Alloantigen-Pulsed Host Dendritic Cells Induce Ag-Specific T Cell Regulation and Prolong Graft Survival. Am J Transplant. 5:228-236.
116. Taylor PA, Lees CJ, Blazar BR. 2002. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 99:3493-3499.
117. Théry C, Boussac M, Véron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S. 2001. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol Baltim Md 1950. 166:7309- 7318.
118. Théry C, Duban L, Segura E, Véron P, Lantz O, Amigorena S. 2002. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol. 3:1156-1162.
119. Thery C, Ostrowski M, Segura E. 2009. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 9:581-593.
120. Théry C, Zitvogel L, Amigorena S. 2002. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2:569-579.
121. Thornton AM, Shevach EM. 2000. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol Baltim Md 1950. 164:183- 190.
122. Turner D. 2004. ES07.02 The human leucocyte antigen (HLA) system. Vox Sang. 87:87-90.
123. Turnquist HR, Raimondi G, Zahorchak AF, Fischer RT, Wang Z, Thomson AW. 2007. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol Baltim Md 1950. 178:7018-7031.
124. Villarroya-Beltri C, Gutiérrez-Vázquez C, Sánchez-Cabo F, Pérez-Hernández D, Vázquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M, Sánchez-Madrid F. 2013. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun [Internet]. 4. Available from: http://dx.doi.org/10.1038/ncomms3980
125. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, et al. 2005. Costimulation Blockade with Belatacept in Renal Transplantation. N Engl J Med. 353:770-781.
126. Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, Pain S, Raposo G, Benaroch P, Bonnerot C. 2002. Exosomes bearing HLA-R1 molecules need dendritic cells to efficiently stimulate specific T cells. Int Immunol. 14:713-722.
127. Wang Z, Larregina AT, Shufesky WJ, Perone MJ, Montecalvo A, Zahorchak AF, Thomson AW, Morelli AE. 2006. Use of the Inhibitory Effect of Apoptotic Cells on Dendritic Cells for Graft Survival Via T-Cell Deletion and Regulatory T Cells. Am J Transplant. 6:1297-1311.
128. Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, Nolte-'t Hoen EN, Piper MG, Sivaraman S, Skog J, et al. 2013. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2.
129. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, et al. 2001. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 7:297-303.
130. Wood KJ, Bushell A, Hester J. 2012. Regulatory immune cells in transplantation. Nat Rev Immunol. 12:417-430.
131. Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. 2013. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 33:1711-1715.
132. Xu D-L, Liu Y, Tan J-M, Li B, Zhong C-P, Zhang X-H, Wu C-Q, Tang X-D. 2004. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells. Scand J Immunol. 59:536- 544.
133. Yamada A, Chandraker A, Laufer TM, Gerth AJ, Sayegh MH, Auchincloss H. 2001. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J Immunol Baltim Md 1950. 167:5522- 5526.
134. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. 2001. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol Baltim Md 1950. 166:7282-7289.
135. Yamazaki S, Dudziak D, Heidkamp GF, Fiorese C, Bonito AJ, Inaba K, Nussenzweig MC, Steinman RM. 2008. CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells. J Immunol. 181:6923-6933.
136. Yang C, Robbins PD. 2012. Immunosuppressive Exosomes: A New Approach for Treating Arthritis. Int J Rheumatol. 2012.
137. Yang X, Meng S, Jiang H, Zhu C, Wu W. 2011. Exosomes Derived from Immature Bone Marrow Dendritic Cells Induce Tolerogenicity of Intestinal Transplantation in Rats. J Surg Res. 171:826-832.
138. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes. Nat Med. 4:594-600.
139. Zoccali C, Kramer A, Jager KJ. 2010. Epidemiology of CKD in Europe: an uncertain scenario. Nephrol Dial Transplant. 25:1731-1733.